Michael H Bloch Selected Research

Molindone (Molindone Hydrochloride)

1/2021	Time to Clinical Response in the Treatment of Early Onset Schizophrenia Spectrum Disorders Study.
1/2018	Predictors and Moderators of Antipsychotic-Related Weight Gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study.
1/2017	Predictors of treatment response and drop out in the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael H Bloch Research Topics

Disease

20	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 12/2021 - 06/2008
12	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 09/2009
12	Anxiety Disorders (Anxiety Disorder) 01/2020 - 04/2012
8	Tics (Tic) 01/2020 - 09/2009
7	Tourette Syndrome (Tourette's Syndrome) 01/2022 - 01/2014
7	Schizophrenia (Dementia Praecox) 01/2021 - 10/2012
6	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2017
6	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 01/2011
5	Tic Disorders (Tic Disorder) 01/2022 - 09/2009
5	Trichotillomania 01/2020 - 01/2007
4	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021 - 03/2015
4	Social Phobia 01/2021 - 03/2015
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 07/2013
3	Mental Disorders (Mental Disorder) 02/2021 - 07/2013
3	Depressive Disorder (Melancholia) 01/2019 - 12/2017
2	Autism Spectrum Disorder 01/2021 - 05/2012
2	Treatment-Resistant Depressive Disorder 01/2021 - 01/2021
2	Separation Anxiety (Separation Anxiety Disorder) 01/2019 - 03/2018
2	Weight Gain 01/2018 - 01/2018
2	Sleep Wake Disorders 01/2018 - 01/2013
2	Neoplasms (Cancer) 06/2015 - 11/2004
2	Panic Disorder (Panic Attack) 06/2015 - 03/2015
2	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2014 - 01/2013
1	Mood Disorders (Mood Disorder) 02/2021
1	Tardive Dyskinesia 01/2020
1	Autistic Disorder (Autism) 12/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2019
1	Headache (Headaches) 01/2018
1	Hyperprolactinemia 01/2018
1	Hyperhidrosis 12/2017
1	Disease Progression 06/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Cognitive Dysfunction 01/2017
1	Disorders of Excessive Somnolence (Hypersomnia) 10/2016

Drug/Important Bio-Agent (IBA)

13	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2020 - 10/2007
9	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 07/2013
8	Antidepressive Agents (Antidepressants)IBA 12/2021 - 07/2013
6	Ketamine FDA LinkGeneric 01/2021 - 12/2012
5	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2021 - 11/2015
5	Acetylcysteine (Siran)FDA LinkGeneric 01/2020 - 03/2013
4	Methylphenidate (Ritalin)FDA LinkGeneric 01/2022 - 09/2009
4	Olanzapine (Zyprexa)FDA Link 01/2021 - 11/2015
4	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2021 - 09/2009
4	Glutamic Acid (Glutamate)FDA Link 01/2020 - 12/2011
3	Molindone (Molindone Hydrochloride)FDA Link 01/2021 - 01/2017
3	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 12/2017
3	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2019 - 12/2017
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2019 - 10/2011
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018 - 10/2012
3	MelatoninIBA 01/2018 - 01/2013
3	Riluzole FDA LinkGeneric 08/2015 - 01/2007
2	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2022 - 01/2020
2	BenzodiazepinesIBA 01/2020 - 10/2017
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019 - 12/2017
2	Eicosapentaenoic AcidIBA 01/2019 - 10/2011
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2018 - 10/2014
2	Bupropion (Wellbutrin)FDA LinkGeneric 01/2018 - 12/2017
2	Pemetrexed (MTA)FDA Link 10/2017 - 06/2017
2	Pharmaceutical PreparationsIBA 01/2017 - 09/2009
2	Clomipramine (Anafranil)FDA LinkGeneric 10/2016 - 10/2007
2	Hypnotics and Sedatives (Sedatives)IBA 10/2016 - 07/2013
1	LithiumIBA 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	Clozapine (Clozaril)FDA LinkGeneric 01/2022
1	AmphetaminesIBA 01/2022
1	Midazolam (Versed)FDA LinkGeneric 01/2021
1	Guanfacine (Tenex)FDA LinkGeneric 01/2021
1	Dronabinol (THC)FDA LinkGeneric 01/2021
1	Aripiprazole (Abilify)FDA Link 01/2021
1	palmidrolIBA 01/2021
1	Anesthetics (Anesthetic Agents)IBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2020
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2020
1	trans-sodium crocetinate (crocetin)IBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Docosahexaenoic AcidsIBA 01/2019
1	Biological ProductsIBA 01/2019
1	CannabinoidsIBA 01/2019
1	Sertraline (Zoloft)FDA LinkGeneric 03/2018
1	ProlactinIBA 01/2018
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Escitalopram FDA Link 01/2018
1	Saline SolutionIBA 01/2018
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 12/2017
1	Fluvoxamine (Luvox)FDA LinkGeneric 12/2017
1	VortioxetineIBA 12/2017
1	AntioxidantsIBA 07/2017
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2017
1	Pharmacologic ActionsIBA 01/2016
1	Perphenazine (Trilafon)FDA LinkGeneric 11/2015
1	ziprasidone (Geodon)FDA Link 11/2015

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 01/2021 - 11/2004
6	Therapeutics 01/2022 - 10/2007
3	Combined Modality Therapy 10/2017 - 05/2017
2	Contraindications 07/2012 - 09/2009
1	Intravenous Infusions 01/2021
1	Neurofeedback 01/2020
1	Deep Brain Stimulation 01/2017